AZTA GoodMoat Verdict
Full signal breakdown coming soon. Use the X-Ray tool for a detailed analysis.
Azenta Inc
Exchange: NASDAQSector: HealthcareIndustry: Medical Instruments & Supplies
Brooks operates two global, market-leading businesses, Life Sciences and Semiconductor Solutions, each with its own distinct area of focus and expertise. The Life Sciences business, to be operated under the new Azenta brand, provides a full suite of reliable cold-chain sample management solutions and genomic services across areas such as drug development, clinical research and advanced cell therapies for the industry's top pharmaceutical, biotech, academic and healthcare institutions globally. On September 20, 2021, the Company announced the pending sale to Thomas H. Lee Partners of its Semiconductor Solutions Group business, which provides industry-leading precision vacuum robotics, integrated automation systems and contamination control solutions to the world's leading semiconductor chip makers and equipment manufacturers as well as collaborative robotics and automation capabilities for multi-market applications. Brooks is headquartered in Chelmsford, MA, with operations in North America, Europe and Asia.
Did you know?
Generated $1.1 in free cash flow for every $1 of capital expenditure in FY25.
Current Price
$24.91
+1.38%GoodMoat Value
$30.79
23.6% undervaluedProfile
Valuation (TTM)
Market Cap$1.14B
P/E-19.71
EV—
P/B0.66
Shares Out45.78M
P/Sales1.92
Revenue$594.95M
EV/EBITDA—
Azenta Inc (AZTA) Quality Analysis
AZTA Profitability
Profitability trend analysis coming soon
AZTA Growth
Growth trend analysis coming soon
AZTA Financial Health
Financial health indicators coming soon
AZTA Quality & Fundamental Analysis
Azenta Inc (AZTA) is a Healthcare company in the Medical Instruments & Supplies industry, listed on NASDAQ. This quality analysis page evaluates Azenta Inc's financial health using the Piotroski F-Score methodology, profitability ratios, growth trajectory, and balance sheet strength.
Azenta Inc has a Piotroski F-Score of N/A out of 9, measuring profitability, leverage, and operating efficiency. The company operates with a profit margin of -9.72% and a return on equity (ROE) of -3.35%. Return on assets (ROA) stands at -2.81%.
The debt-to-equity ratio is 0.03, with a current ratio of 2.98. Operating margin is -4.52%.
GoodMoat's quality analysis uses AI-powered insights to evaluate whether Azenta Inc is a fundamentally sound investment. The GoodMoat Verdict synthesizes profitability, growth, and financial health scores into a clear investment quality rating. Use these metrics alongside valuation tools like the DCF calculator and fair value models to make informed investment decisions.